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Abstract
Background: The human NECDIN gene is involved in a neurodevelopmental disorder, Prader-
Willi syndrome (PWS). Previously we reported a mouse Necdin knock-out model with similar
defects to PWS patients. Despite the putative roles attributed to Necdin, mainly from in vitro
studies, its in vivo function remains unclear. In this study, we investigate sensory-motor behaviour
in Necdin deficient mice. We reveal cellular defects and analyse their cause.
Results: We report sensory differences in Necdin deficient mice compared to wild type animals.
These differences led us to investigate sensory neuron development in Necdin deficient mouse
embryos. First, we describe the expression pattern of Necdin in developing DRGs and report a
reduction of one-third in specified sensory neurons in dorsal roots ganglia and show that this
neuronal loss is achieved by E13.5, when DRGs sensory neurons are specified. In parallel, we
observed an increase of 41% in neuronal apoptosis during the wave of naturally occurring cell death
at E12.5. Since it is assumed that Necdin is a P75NTR interactor, we looked at the P75NTR-
expressing cell population in Necdin knock-out embryos. Unexpectedly, Necdin loss of function
has no effect on p75NTR expressing neurons suggesting no direct genetic interaction between
Necdin and P75NTR in this context.
Although we exclude a role of Necdin in axonal outgrowth from spinal sensory neurons in early
developmental stages; such a role could occur later in neuronal differentiation. Finally we also
exclude an anti-proliferative role of Necdin in developing sensory neurons.
Conclusion: Overall, our data show clearly that, in early development of the nervous system,
Necdin is an anti-apoptotic or survival factor.
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Background
Molecules that orchestrate the cell cycle have to interact
with extrinsic signals to trigger neural cell specification
and differentiation [1,2]. Discovered 15 years ago, NEC-
DIN (Neurally differentiated Embryonal Carcinoma-
Derived proteIN, [3]), possesses all the characteristics of
such a molecule as described in the literature [4,5]. Nec-
din belongs to the type II MAGE (Melanoma Antigen
Gene Expression) gene family, all of whose members
share a MAGE Homology Domain (MHD) of an as yet
unknown function [5,6].
Different roles, mainly based on in vitro studies, have been
assigned to Necdin. The mouse Necdin protein was first
defined as a "growth-suppressor" that could facilitate the
cell cycle exit and the maintenance of the neuronal post-
mitotic state [7-10]. A role in neuronal terminal differen-
tiation, more specifically in neurite outgrowth and
fasciculation was also supported by a number of studies
[8,11-13]. This role is thought to implicate the Nerve
Growth Factor (NGF) signalling pathway [8,11,12] and/
or a signalling pathway involving centrosomal function
and cytoskeletal rearrangement [13]. Supporting these
findings, a large variety of Necdin partners have been
revealed using yeast two-hybrids or Ras Rescue Systems.
Necdin cytoplasmic interactors (FEZ1, BBS4, NEFA and
Nuc which are both Ca2+ binding proteins), or nuclear
interactors such as cell-cycle proteins (E2F1, E2F2, p53)
and neurotrophic receptors (p75NTR, TrkA) have been
characterized.
Interestingly, it is not only Necdin but also other members
of the family such as NRAGE and MAGEH1 which interact
with the death domain of the low affinity receptor to neu-
rotrophin p75NTR [5,12,14,15].
As most of these data were obtained from in vitro experi-
ments, their physiological relevance remained to be dem-
onstrated. Thus, by focusing on the nervous system, we
asked whether Necdin plays a unique role via a single sig-
nalling pathway or different roles, as suggested by the in
vitro experiments, depending on the cell type and on the
physiological context. Effectively, the Necdin expression
profile in mouse is consistent with a role in neuronal dif-
ferentiation including cell cycle arrest, neuronal matura-
tion and later in maintaining a post-mitotic state [16].
The human NECDIN gene is deleted in the Prader-Willi
syndrome (PWS) [17-19], a complex multigenic neuroge-
netic disease. PWS is mainly characterized by a transient
infantile hypotonia, global development delay, hyper-
phagia leading to severe obesity and many other clinical
features (hypogonadism, cognitive impairments, skin
picking, daytime sleepiness, temperature instability,
abnormal ventilatory responses...) [20].
Four different Necdin-null mouse models [18,19,21,22]
have been generated in order to reveal the physiological
and pathophysiological role of Necdin. At first glance,
these mice show no obvious abnormal phenotype. Never-
theless, some phenotypic characteristics reveal striking
parallels with the phenotypic manifestations in PWS
patients: such as a high level of scraping, a particular cog-
nitive profile [21] and, more importantly, depending on
the genetic background, postnatal respiratory distress
leading to lethality [18,21]. Up to now, the phenotype
description of the Necdin knock-out (Ndn KO) model is
still partial and further analysis could reveal other altera-
tions similar to PW symptoms.
Finally, subtle morphological abnormalities were also
reported suggesting that Necdin deficiency results in aber-
rant neuronal migration and affects axonal extension,
arborization and fasciculation during development
[13,23].
Here, in order to clarify the functional roles of Necdin in
the cellular physiology of the nervous system, we investi-
gate the sensory system. First, we explore the sensory-
motor behaviour and reveal sensory deficits that might
result from Necdin deficiency. Then, to address the func-
tion of Necdin at the cellular level we examine the integ-
rity of Dorsal Root Ganglias (DRGs) in Necdin mutant
embryos (Ndn KO) we have previously generated [21].
We analyse carefully the spatio-temporal expression pat-
tern of Necdin in the developing sensory neurons. We
observe a significative loss of TrkA and TrkC sensory neu-
rons in Ndn KO compared to wild type; this loss is
achieved at E13.5 dpc and remains at P0. We reveal an
increase of caspase3-dependant apoptosis, before the
peak of naturally occurring cell death. This cell death does
not involve the P75NTR receptor.
We also investigate the axonal outgrowth in several struc-
tures innervated by the spinal sensory neurons in Necdin
mutants.
Results
Phenotypic features suggest defects of sensory pathways
Phenotypical analysis is performed on 7 wild type and 9
mutant adult mice (3–4 months) (Table 1). Ndn KO mice
had normal body weight and body temperature (Table 1),
well-groomed coats, and normal body posture. Gross neu-
rological examination of animals reveals no distinct signs
of modified sensory or vestibular reflexes in mutants as
assessed in simple tests of vision, audition, olfaction,
touch sensitivity or righting reflex. Necdin mutants also
show a normal reactivity to handling and a normal
exploratory activity when exposed to a novel cage imme-
diately following the transfer arousal test.BMC Developmental Biology 2006, 6:56 http://www.biomedcentral.com/1471-213X/6/56
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We explored further the sensory-motor abilities and gen-
eral behaviour of Necdin adult deficient mice using spe-
cific behavioural tests. Mutant mice had comparable level
of spontaneous activity to wild types, as revealed by the
distance travelled and number of rears in the open field
test (Table 2). The number of entries and percentage of
time spent in the center of the open field arena was also
comparable between genotypes, suggesting that Necdin
deletion has no effect on anxiety at least in this test. When
analyzed for specific motor abilities, mutant mice per-
formed as well as the wild type mice in the grip and string
tests, showing that muscle strength and traction force are
not affected in mutants (Table 1). On the other hand, the
time spent in an accelerated rotarod was reduced and the
latency to reach the goal platform in the beam walking
test was significantly increased (p < 0.05; Table 1) in Nec-
din deficient mice as compared to wild type, suggesting
motor coordination or balance deficits in mutants.
Mutant mice also showed a higher tendency to slip off
with the hind limbs that might be interpreted as altered
proprioceptive sensitivity.
Electrophysiological tests to evaluate innervation of
peripheral targets and spinal cord reflexes, were per-
formed on hindlimbs (Table 3). The sensory nerve con-
duction velocity (SNCV) is comparable between wild type
and Necdin deficient mice. The compound muscle action
potentials including the direct muscle response (M-wave)
at the level of the gastrocnemius or plantar muscles, and
the monosynaptic reflex response (H-wave) on the
plantar muscle were also recorded. Amplitude and latency
of the M-wave were not significantly different between
mutant and wild type mice. On the other hand, the H-
wave amplitude and the H/M amplitude ratio, recorded
on the plantar muscle, were significantly higher in the
mutant group (p < 0.05). The H-reflex amplitude and the
H/M amplitude ratio have been used traditionally to eval-
uate spinal excitability. These data suggest an overall facil-
itation of the stretch reflex circuit (H-reflex) that could
result from hyperexcitability of motoneurons and/or sen-
sory neurons.
Finally, the hot plate test was used to evaluate pain sensi-
tivity and revealed significantly reduced withdrawal
latency in mutant mice compared to wild type animals (p
< 0.05; Table 4), thus suggesting reduced pain threshold
in Necdin deficient mice.
Taken together these data reveal significant defects in the
sensory system.
Expression of Necdin in developing DRGs
In order to detect histological abnormalities in lumbar
DRGs that could be correlated to the sensory dysfunction
in Ndn KO mice, we first analysed the morphology and
the size of lumbar DRGs. At P0, comparing the volume of
the first lumbar (L1) DRG between Ndn KO and wild type
mice (WT), we observed a 37% reduction of the mutant
L1 DRG volume (WT: 32 105 μm3 (30 105, 32.7 105), n =
3; Ndn KO: 19.7 105 μm3 (17.2 105, 21.4 105), n = 3).
Since previously, we have shown that Necdin is expressed
through embryogenesis in postmitotic neurons [16], we
hypothesized that a defect during the ontogeny of sensory
neurons in Necdin deficient mice might result in a loss or
Table 2: Open Field
Wild type Ndn-KO
Distance traveled (cm) 12965(11228,13406) 13186((11704, 14717)
Time spent in center (%) 5.4 (4.9, 7.3) 6.3 (5.3,7.3)
Entries in center (nb) 78 (70, 94) 88 (85, 106)
Rearings (nb) 265 (219,275) 249 (188, 295)
Values indicated represent the median and, between brackets, the interquartile range.
Table 1: Neurological evaluation
Wild type Ndn-KO
Body weight (g) 25.20 (0.55) 25.80 (1.75)
Body temperature (°C) 36.40 (1.03) 36.60 (0.60)
String test (s) 8.98 (20.62) 7.37 (2.66)
Grip strength (s) 7.90 (0.98) 7.67 (1.85)
Rotarod-4 to 40 rpm in 5 min (s) 117.50 (76.38) 90.50 (69.88)
Beam walking (s) Number of slips 1.0 (0.25) 2 (2.40)
Latency (s) 11.59 (4.10) 14.66 (2.39) *
Values indicated represent the median and, between brackets, the interquartile range. * p < 0.05, Mann-WhitneyBMC Developmental Biology 2006, 6:56 http://www.biomedcentral.com/1471-213X/6/56
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pronounced atrophy of sensory neurons resulting in a
reduction of L1 DRGs volume in Necdin deficient mice. In
developing DRGs, expression of Necdin transcript is first
detected at E11.5 and progressively increases to E13.5, in
accordance with an increasing number of neurons present
in ganglia (Fig. 1A–C). At E13.5, using the thymidine ana-
logue bromodeoxyuridine (BrdU), to label proliferative
cells, we revealed the absence of Necdin expression in
BrdU-positive cells (Fig. 1E); however we showed a cola-
belling of Necdin and Neurofilament (NF) by immuno-
histochemistry (IH) (Fig. 1D). Therefore, in developing
DRGs, Necdin is clearly expressed in post-mitotic neurons
and not in the progenitor cells as it has been shown in
other brain structures [16]. Necdin protein is detected in
the nucleus and the cytoplasm (Fig. 1F), as confirmed by
confocal analysis (not shown).
In an attempt to determine which class of specified DRG
neurons express Necdin, we examined the expression of
the three tyrosine kinase receptors (Trk), TrkA, TrkB and
TrkC; characterizing respectively NGF responding nocice-
ptive neurons, BDNF responsive neurons and NT3
responsive proprioceptive neurons [24]. At E13.5, In Situ
Hybridization using the riboprobes Trka (Fig. 2A), Trkb
(Fig. 2B) and Trkc (Fig. 2C) combined with immunostain-
ing using Necdin antibodies showed that all Trkc- and
Trkb-expressing neurons, as well as a significantly high
number (80%) of Trka-expressing neurons, co-expressed
Necdin.
Lack of Necdin causes embryonic loss of sensory neurons
With regard to Necdin expression, we examined more
closely the TrkA, TrkB and TrkC sensory neuron subpopu-
lations. As these populations are highly dynamic through
gangliogenesis [25], we studied different embryonic
stages from E11.5, when discernible DRGs are formed, to
E13.5, when DRG neurons are specified. At all stages,
Trka,  Trkb  and  Trkc  expressing cells were detected in
mutant mice as shown at E13.5 (Fig. 2G–I). At E11.5 a
quantitative analysis of each Trk-expressing cell subpopu-
lation in lumbar DRGs (L1 to L5), revealed no difference
between wild type and mutant embryos (data not shown).
At E13.5, the morphological appearance and the volume
of lumbar DRGs are similar in mutant and wild type
embryos. However,, the pool of lumbar DRGs revealed a
significant reduction of 26.2% in the density of Trka-
expressing cells (WT: 2258 (1999, 2530), n = 5; Ndn KO:
1714 (1450, 1811), n = 5; *p < 0.05) (Fig. 2D,G,J) and a
reduction of 37.8% in Trkc-positive neurons (WT: 292
(277, 321), n = 5; Ndn KO: 188 (157, 223), n = 5; *p <
0.05) (Fig. 2F,I,J)) in the mutant embryos. The density of
Trkb-expressing neurons was not affected (WT: 113 (89,
143), n = 5; Ndn KO: 102 (74, 133), n = 5) (Fig. 2E,H,J).
At P0, in order to confirm the loss of sensory neurons in
Ndn-KO DRGs, we compared the expression of TrkA in L1
DRGs specifically, between mutant and wild type
neonates (WT: 2050 (1700, 2310), n = 3; Ndn KO: 1243
(1065, 1680), n = 3).
These data indicate that the abrogation of Necdin results
in a partial loss of sensory neurons expressing TrkA and
TrkC receptors. This loss occurs in early embryonic devel-
opment and is maintained at birth. The number of TrkB-
expressing neurons appears similar in mutant and wild
type animals.
Apoptotic cell death is increased in developing DRG 
neurons in Necdin mutant
As the physiological wave of cell death among DRGs neu-
rons occurs mainly from E12.5 to E14.5 [26], we hypoth-
esized that an increase of cell death could be responsible
Table 4: Pain sensitivity
Wild type Ndn-KO
Hot plate latency (s) 9.13 (2.08) 7.05 (1.23) *
Tail flick latency (s) 3.77 (0.98) 3.03 (0.28)
Values indicated represent the median and, between brackets, the interquartile range. * p < 0.05, Mann-Whitney
Table 3: EMG measurements
Wild type Ndn KO
Sensory Nerve Conduction Velocity (m/s) 38.5 (8.48) 40.00 (11.43)
Plantar muscle CMAP M-wave Latency (s) 1.65 (0.13) 1.58 (0.19)
Amplitude (mV) 4.60 (4.98) 4.50 (1.90)
H-wave Latency (s) 4.60 (0.68) 4.30 (0.20)
Amplitude (mV) 0.40 (0.18) 0.70 (0.20) *
Values indicated represent the median and, between brackets, the interquartile range. * p < 0.05, Mann-WhitneyBMC Developmental Biology 2006, 6:56 http://www.biomedcentral.com/1471-213X/6/56
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for the loss of sensory neurons in Necdin mutants. We
quantified cells undergoing DNA fragmentation, using a
TUNEL assay (terminal deoxynucleotide transferase (tdt)-
mediated dUTP nick end labelling), in the lumbar region
and at different developmental stages (E11.5, E12.5 and
E13.5) (Fig. 3A). In wild type mice, we observed an
increase of apoptosis in the lumbar region between E11.5
and E13.5, as previously reported [26]. In Necdin
mutants, at E11.5 (Fig. 3A), we observed no significant
difference with the wild type control littermate (WT: 8 (7,
10), n = 5; Ndn KO: 17 (9, 20), n = 3). However, at E12.5,
we observed a significant 41% increase in the density of
Expression of Necdin in DRGs through development Figure 1
Expression of Necdin in DRGs through development. (A) Ndn in situ hybridization (ISH) on sagittal section at E13.5 dis-
plays expression in the central and peripheral nervous system, in particular in the forebrain (fb), the midbrain (mb), the hind-
brain (hb) and in the DRGs (arrows). (B, C) Ndn mRNA is detected in developing sensory neurons at E11.5 (B) and E13.5 (C). 
At E12.5, Necdin protein is not expressed in progenitor cells but in post-mitotic neurons. (D) Sections through lumbar DRGs 
of E12.5 embryos co-labelled with anti-Necdin antibody (in red) and with anti-Neurofilament antibody (in green) reveal a co-
localisation between both staining (in yellow). (E) Consecutive sections double-labelled with anti-Necdin antibody (in red) and 
anti-BrdU (in green) show no co-localisation of both markers. (F) Magnification of a lumbar DRG at E13.5 labelled by immuno-
histochemistry using anti-Necdin antibody in combination with Hæchst, to look at the subcellular localisation of Necdin. Nec-
din is detected in the cytoplasm and nucleus of cells. Arrowheads indicate examples of both weak and strong expression level 
of Necdin in sensory neurons that are readily observable at E13.5. Scale bar: 200 μm (A); 50 μm (B and C); 100 μm (D, E and 
F).
AB C
fb mb hb
D E F
E11.5 E13.5
Ndn
E13.5
Ndn
BrdU Ndn NF NdnBMC Developmental Biology 2006, 6:56 http://www.biomedcentral.com/1471-213X/6/56
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Reduction of the number of TrkA- and TrkC-expressing cell in Necdin mutant DRGs Figure 2
Reduction of the number of TrkA- and TrkC-expressing cell in Necdin mutant DRGs. (A-C) Transverse section of 
E13.5 embryos double-labelled with an anti-Necdin antibody and with the riboprobes of Trka (A) or Trkb (B) or Trkc (C) 
respectively. In situ hybridisation on sections of lumbar DRGs from E13.5 wild type (D-F) and Necdin mutant (G-I) embryos 
with the riboprobes Trka (D, G), Trkb (E, H) and Trkc (F, I). (J) Number of Trk-expressing neurons in lumbar DRGs at E13.5. 
Shown are the box-plots, describing the number of neurons per square millimetre for five ganglia from five embryos of each 
genotype (mutant or wild type). Significant loss of TrkA- and TrkC-subpopulations is observed. Statistical comparisons are 
made using the Mann-Whitney test; asterisks show differences that are statistically significant (*, p < 0.05). Scale bar: 100 μm 
(A-I).
Trka Trkb Trkc
A B C
DEF
E13.5
GH I
J
* *BMC Developmental Biology 2006, 6:56 http://www.biomedcentral.com/1471-213X/6/56
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TUNEL positive cells in mutants compared to control
DRGs (WT: 68 (62, 75), n = 4; Ndn KO: 117 (108, 127),
n = 3; * p < 0.05) (Fig. 3A). Finally, at E13.5, the density
of TUNEL positive cells was equivalent in both mutants
and wild type (WT: 180 (163, 199), n = 3; Ndn KO: 170
(159, 177), n = 3). Double labelling using the TUNEL
assay and immunostaining with anti-NF (Fig. 3B)
revealed a colocalisation of both markers, indicating that
dying cells are mainly post-mitotic. In accordance, TUNEL
staining combined with BrdU labelling (Fig. 3C) indi-
cated that  are not affected.
Finally, in mutant mice, we compared serial sections
marked either with FluoroJade, a marker of non specific
neuronal degeneration [27], or with TUNEL staining.
These two labellings, gave a similar, scattered pattern of
stained neurons suggesting no increase of a necrotic non-
apoptotic process in mutant DRGs (data not shown).
In conclusion, we observed an increase of apoptosis in
Necdin mutant lumbar DRG mice at E12.5 precisely, just
before the normal peak of cell death occurring at E13.5.
This cell death is restricted to neurons and does not affect
progenitors.
The increase of apoptosis observed in early sensory neuron 
development of Necdin deficient mice is not dependent on 
p75NTR
Different studies suggest that Necdin could be involved in
the signalling pathway mediated by p75NTR
[12,15,16,22]. Interestingly, mice with a targeted deletion
in p75NTR show a partial loss of sensory neurons in DRGs
[28,29]. We propose that if the sensory neurons lost in
Necdin mutant embryos are those expressing p75NTR,
then we would expect, at E13.5, a reduction of the number
of neurons expressing p75NTR in Necdin mutant mice.
Initially, in wild type embryos, we clarified the expression
pattern of P75NTR in sensory neurons. We performed
three separate double labelling experiments with a
p75NTR riboprobe and either an anti-Islet1/2 antibody
(Fig. 4A), an anti-Necdin antibody (Fig 4B), or an anti-
Runx3 antibody, labelling the TrkC expressing neurons
(Fig. 4C). Colabelling results showed that p75NTR  is
expressed only in a subset of sensory neurons (Islet1/2-
positive), in a subpopulation of Necdin expressing neu-
rons and more particularly in 40% of proprioceptive
(TrkC) neurons (Runx3-positive). Noticeably, an equiva-
lent amount (37.8%) of Trkc-positive cells was lost in Nec-
din deficient mice.
We then compared the number of cells expressing
p75NTR in the lumbar DRGs of wild type and Necdin
mutant. At E13.5 (Fig. 4D), the quantification of the
p75NTR-expressing cells did not reveal any difference
between wild type and mutant lumbar DRGs (WT: 286
(223, 346), n = 3; Ndn KO: 246 (154, 262), n = 5). At
E15.5, this quantification is similar (WT: 327 (257, 386),
n = 3; Ndn KO: 312 (280, 346), n = 4) as at P0 (WT: 1816
(1730, 1880), n = 4; Ndn KO: 1833 (1813, 1949), n = 3).
Indeed, these results show that cell death observed in Nec-
din mutant DRGs does not affect specifically the p75NTR-
expressing neurons and consequently does not directly
involve the p75NTR-signalling pathway.
Neurite outgrowth in developing sensory neurons of 
Necdin mutants
To investigate whether Necdin is required for axonal elon-
gation in sensory neurons as has been previously sug-
gested, in the superior cervical ganglia at E18 [23], we
examined the axonal outgrowth in wild type and mutant
embryos in several structures innervated by the DRGs sen-
sory neurons. First, we performed a whole-mount immu-
nostaining using anti-β tubulin III (Tuj1) antibody, an
axonal marker, to visualize the morphology and to meas-
ure the length of axons in mutants compared to wild type
(Fig. 5A). We analyzed different nerves along the rostro-
caudal axis. At E11.5, in Necdin mutant embryos, the bra-
chial plexus, formed by the last three cervical and first two
thoracic nerves, in the forelimb was appropriately pat-
terned and all nerves emanating from it appear normal
compared to wild type (data not shown). At E12.5 and
E13.5, peripheral spinal nerves were analysed quantita-
tively by measuring the length of nerves (given in μm)
innervating the trunk region. Statistical analysis did not
reveal any difference between mutant and wild type nei-
ther at E12.5 (WT: 227 (206, 252), n = 4; Ndn KO: 224
(195, 230), n = 5) nor at E13.5 (WT: 979 (935, 1025), n =
7; Ndn KO: 959 (930, 1066), n = 9) (Fig. 5B). Thus, at
early stages of development (E11.5 to E13.5) our data sug-
gest that Necdin does not play a major role in axonal
growth in those structures.
At E17.5, when sensory axons from DRG reach their tar-
gets, we examined whether axonal projections were cor-
rectly patterned. We performed immunohistochemistry
with anti-Parvalbumin antibody (PV), which detects spe-
cifically proprioceptive (TrkC) afferent fibers entering the
spinal cord [30] (Fig. 5C and 5D). Comparison of PV-
immunoreactive fibers in control (Fig. 5C) and Necdin
mutant mice (Fig. 5D) showed that axons extend correctly
ventro-laterally through the gray matter from the dorsal
column to the ventral horn. However, in mutant mice, PV-
immunostaining showed a difference in the region of the
intermediate spinal cord, close to a set of Islet-positive
neurons located in the deep dorsal horn [30]. We clearly
observed that afferent projections from the proprioceptive
neurons are reduced in the intermediate spinal cord (Fig.
5E).BMC Developmental Biology 2006, 6:56 http://www.biomedcentral.com/1471-213X/6/56
Page 8 of 18
(page number not for citation purposes)
Increase of apoptosis in the Necdin mutant DRGs Figure 3
Increase of apoptosis in the Necdin mutant DRGs. (A) Time course of TUNEL staining in lumbar DRGs. Shown are the 
box-plots describing the number of TUNEL positive cells for lumbar DRGs; statistical comparisons were made using the Mann-
Whitney test; asterisks show differences that are statistically significant (*, p < 0.05). (B) Double immunofluorescence labelling 
for TUNEL (in red) and Neurofilament (in green) in a lumbar ganglion of an E12.5 mutant embryo. In this figure, one immuno-
positive-cell for Neurofilament in the field whose nuclei are labelled by the apoptosis detection method (arrow). (C) Double-
labelling for TUNEL (in red) and BrdU (in green) after 2 hr injection; co-labelling was never observed, indicating that precur-
sors are not dying in the Necdin mutant animals. Scale bar: 10 μm (B and C).
A
BC
NF Tunel Brdu Tunel
*BMC Developmental Biology 2006, 6:56 http://www.biomedcentral.com/1471-213X/6/56
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Finally at P0 and at adulthood, we examined the cutane-
ous innervation in the hindpads of mice, revealed by
using immunofluorescence with an antibody for calci-
tonin gene-related product (CGRP), a marker of nocicep-
tive (TrkA) afferent fibers. At P0 and adulthood, CGRP-
immunoreactive fibers are found in the epidermis, around
the hair follicles, in the upper dermis and around blood
vessels as in wild type animals (Fig. 5F and 5H) and as
previously described [31]. However, we noticed a reduc-
tion in the number of CGRP-immunoreactive fibers in
mutant mice.
In conclusion, we did not observe any gross impairment
of axonal outgrowth in early developmental stages
(E11.5–E13.5) in our Ndn KO embryos. Later in develop-
ment and in adult, we showed that PV-fibers and CGRP-
fibers that express TrkC and TrkA respectively are correctly
patterned; however we detected a reduction in the
number of fibers.
Since we did not observe any gross impairment of axonal
outgrowth in our Ndn KO mice although others have
reported such defects, specifically in vitro [11], we then
assessed in vitro the role of Necdin on neurite outgrowth
In vivo, cell death in Necdin mutant developing DRGs is not dependent on P75NTR Figure 4
In vivo, cell death in Necdin mutant developing DRGs is not dependent on P75NTR. (A-C) DRG sensory neurons 
at E13.5 on a transverse section are double-labelled with p75NTR mRNA and Islet1/2 (A), or with Necdin (B) or with Runx3 
antibodies, a marker of proprioceptive sensory neurons (C). In each case, colabelling reveal a partial co-expression. (D) Quan-
tification of the number of p75NTR-positive cells in mutant compared to the wild type at distinct developmental stage. Shown 
are the box-plots describing the numbers of p75-expressing cells per square millimetre at E13.5 and E15.5, and statistical com-
parisons were made using the Mann-Whitney test. Scale bar : 100 μm (A and C); 50 μm (B).
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P75 Runx3
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In vivo analysis of axonal growth in Necdin mutant embryos Figure 5
In vivo analysis of axonal growth in Necdin mutant embryos. (A) Whole-mount immunostaining of E13.5 wild type and 
mutant embryos with TuJ1, a neuronal specific marker illustrating the parameter used for quantification (lcb). (B) Quantitative 
analysis of the length of the lateral cutaneous branches of the nerves innervating the trunk at E12.5 and E13.5. No significant 
differences in the length of spinal nerves were observed in mutant embryos compared to wild type. Six peripheral axon bun-
dles, from five mice, for each genotype, were analyzed. Statistical analysis was carried out using the Mann-Whitney test. (C, D) 
Parvalbumin immunostaining on transverse section at E17.5 showing a decrease of Necdin mutant proprioceptive afferences 
(D) in spinal cord compared to wild type (C). (E) Representative scheme of defect observed in (C) and (D). (F-I) CGRP immu-
nostaining on coronal section, at adulthood, showing a similar innervation pattern of TrkA fibers in the hindpaw pad (F-G) 
around an hair follicle or (H-I) in the epidermis under nail of the second toe in NdnKO (G, I) or wild type (F-H) mice. We 
notice a decrease in the number of fibers in Ndn KO. ab, anterior bud; Ep, epidermis; HF, hair follicle; lcb, lateral cutaneous 
branch. Scale bar: 500 μm (A); 100 μm (C, D and F-I).
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lcb ab
DRGs
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PV
F G Ndn KO WT
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as it has been shown in a different Ndn-KO mutant [22].
DRG explants isolated from E13.5 were cultured for 48
hours in the presence of either the neurotrophic factor
NT3 or NGF. In the presence of NT3, DRG explants from
wild type and KO extended neurites with similar length
(data not shown). However, in the presence of NGF, a sig-
nificant reduction of 18,3% (Fig. 6H) was observed in the
length of neurites in Necdin mutant explants cultured,
compared to the control (Fig. 6), suggesting that Necdin
deficiency impairs the neurites extension induced by NGF
signalling in DRGs explants.
Discussion
Until now, Necdin function was investigated mainly by in
vitro experiments, which suggested a role of Necdin during
proliferation, in neuronal differentiation and/or apopto-
sis. Here, using a Necdin knock-out mouse model, we
have first analysed the sensory-motor function in adult
mutants and second investigated the in vivo cellular func-
tion of Necdin during the development of the mouse
nervous system and in particular in sensory neurons of
DRGs.
In this instance, DRGs are a system well adapted to study
the cellular function of Necdin in the nervous system. In
DRGs, neural progenitors coexist with differentiated sen-
sory neurons throughout all of neurogenesis and the
ontogeny of sensory neurons is well characterized in
terms of origins, proliferation, determination, cell death
and neuronal survival [26].
Necdin prevents apoptosis in early developing sensory 
neurons
Thus Necdin deficiency impairs lumbar sensory neuron
development between E11.5 and E13.5, resulting in a loss
of sensory neurons persisting at P0 and at adulthood (FM
personal data). During this time frame, we observed in
our control mice a wave of naturally occurring cell death
as previously described [26]. We revealed a significant
41% increase of cell death in lumbar Necdin mutant
DRGs compared to wild type. This increase concerns post-
mitotic neurons only and occurs at E12.5, just before the
peak of naturally cell death, which is observed in normal
mice at E13.5. This increase of cell death was confirmed
by Caspase-3 staining and Hoechst incorporation (data
not shown). Thus, abrogation of Necdin triggers an
increase of early apoptosis via the Caspase-3 pathway.
Notably, this increase of apoptosis and subsequently the
loss of sensory neurons observed in Necdin mutant are
specific to the lumbar region. No defect is detected at the
thoraco-brachial level (Additional File 1). However, at
E13.5, a similar loss of sensory neurons was obtained in
the primary sensory neurons of the trigeminal ganglia
(Additional File 2).
Clearly, at the cellular level, Necdin prevents apoptosis
but the mechanism is unclear. Necdin could be an anti-
apoptotic factor or equally it could be having a positive
survival effect on the sensory neurons (Fig. 7A).
Are specific neurotrophic factors and/or neurotrophic 
receptors involved in Necdin signalling pathway(s)?
The wave of cell death in normal developing DRGs, at
E13.5, occurs before sensory axons have reached their tar-
gets and before neurons are actually exposed to target
derived neurotrophic factors [32,33]. Thus, at E12.5, the
role of Necdin is probably independent of neurotrophic
factors provided by the target. However Necdin signaling
pathway might depend on local action of neurotrophins
or other growth factors.
The timing of neurotrophin/Trk signalling requirements
and the cell types affected by the neurotrophin deficien-
cies have been well studied [26]. It is assumed that a single
neurotrophic factor might promote the survival of a spe-
cific population of sensory neurons, although phenotypic
comparisons among mice with different mutations have
Abrogation of Necdin imparts neuritic extension in explants  DRGs Figure 6
Abrogation of Necdin imparts neuritic extension in 
explants DRGs. (A, B) Photomicrographs of DRGs from 
E13.5 wild type (A), and Necdin mutant (B) embryos, cul-
tured for 20 hr in the presence of NGF only (100 ng/ml). In 
three separate experiments, performed in four mutant and 
wild type lumbar DRGs, significant NGF effect was observed 
in explants derived from Necdin mutants (C). Scale bar: 100 
μm (A and B).
A B
NF
Ndn KO WT
WT
Ndn KO WT
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revealed a considerable overlap in terms of neurotrophin
requirements [34]. The abrogation of Necdin results in a
relatively selective loss of neurons in DRGs: TrkA and
TrkC cell populations are reduced but not TrkB popula-
tion. A simple interpretation of that might be that Necdin
transduces a survival signal of NGF via TrkA (as previously
proposed [22]) or/and of NT3 via TrkC. Considering that
neurogenesis in developing DRGs is a dynamic process
and the expression patterns of the different Trk proteins
are also highly dynamic between E10.5 and E13.5,
Putative role of Necdin during development Figure 7
Putative role of Necdin during development. (A) Schematic representation of Necdin functions in nervous system in vivo. 
(B and C) Cell death in early embryos at E10.5 assessed by Caspase3-immunostaining in wild type (B) and mutant (C) embryos.
A
B C
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another interpretation is that the TrkA and TrkC popula-
tions present at E13.5 expressed a common receptor at an
earlier stage of their development and required a common
neurotrophic factor that could trigger Necdin function as
a survival factor.
Another way to explain the mechanism, by which Necdin
could act as an anti-apoptotic/survival factor, is to con-
sider the p75NTR pathway. Previously, it has been shown
that p75NTR interacts with Necdin [12] and a common
signalling pathway involving Necdin and p75NTR has
been proposed [15,22]. Furthermore, throughout devel-
opment, Necdin and p75NTR expression partially over-
laps in the post-mitotic territories [16]. However, we did
not observe any reduction in the number of neurons
expressing p75NTR in Necdin embryonic DRGs com-
pared to wild type. These data suggest that there is no
direct genetic interaction between p75NTR and Necdin to
prevent the regulated cell death in post-mitotic develop-
ing sensory neurons.
Cell proliferation is not increased in DRGs of Necdin 
deficient mice
Necdin has been demonstrated to function as a "growth
suppressor" in vitro, since its ectopic expression induces an
arrest of cell growth [7,8]. Considering such a role, we
could hypothesize that the increase of cell death observed
in DRGs from mutant mice might be subsequent to a pre-
vious increase of proliferation. Indeed these events are
tightly linked and a compensation mechanism cannot be
excluded [35]. An "anti-proliferative" role of Necdin
should induce, in Necdin deficient DRGs, a reduction in
the pool of post-mitotic generated neurons and an
increase of the number of precursors and/or an increase in
cell death. Three types of data do not support such a role
in developing DRGs: 1) at E11.5, we did not observe any
reduction of the number of Trks expressing cells, includ-
ing the entire pool of post-mitotic neurons at this stage; 2)
we performed BrdU labelling experiments at E13.5 to
assess the amount of proliferation in DRGs and no differ-
ence was observed as checked by analysis on one repre-
sentative lumbar DRG; 3) the increase of apoptosis
observed at E12.5 is restricted to post-mitotic neurons and
neither apoptosis nor necrosis of precursors were
observed.
The abrogation of Necdin does not disturb the axonal 
growth in early stages of neuronal differentiation
Altogether, the analysis of axonal growth made in Necdin
mutant compared to wild type mice, suggests that, in vivo,
Necdin is not involved in early axonal outgrowth. Later in
development at E17.5, we observed a reduced innervation
from the TrkC afferent fibers in the intermediate spinal
cord, visualised by a Parvalbumin labelling. Thus this spe-
cific defect of the TrkC neurons might suggest an involve-
ment of Necdin in axonal growth. However, we have
shown that the lack of Necdin leads to a loss of TrkC
expressing cells that in turn could explain the absence or
reduction of afferent projections. In the same way, we
observed that, qualitatively, the innervation of the CGRP
afferent fibers (TrkA-positive) in the hindpads of wild
type animals is similar in Necdin adult mutant whereas
the number of CGRP-positive nerves appears globally
reduced. Again the loss of Trk A sensory neurons could
explain this difference.
Previous in vitro experiments [11,22] suggest a function of
Necdin in neurite outgrowth depending on NGF. In our
mutant, we investigated whether, independently of the
increase of apoptosis observed, the surviving sensory neu-
rons could normally extend neurites in DRG explants cul-
tures. We revealed a reduction in neurite outgrowth of
E13.5 embryonic DRG mutant explants, dependant on
NGF. This discrepancy between our in vitro results and our
in vivo observations (no defects in axonal growth at E13.5)
might be explained by a role of Necdin in late neuronal
differentiation only. This Necdin function is separable
from its anti-apoptotic role previously revealed. With this
in mind, we report a loss of 27% of TrkA expressing cells
at E13.5 and a 40% loss of TrkA expressing cells at P0, a
substantial reduction between E13.5 and P0. Indeed, a
role of Necdin in neurite outgrowth depending on NGF
might explain this discrepancy: a deficiency in axonal out-
growth would then lead to an alteration of neuronal dif-
ferentiation and an additional loss of TrkA cell death, in
later embryogenesis stages. Furthermore, such a role
would explain the observations reported by other groups
[13,23].
The Necdin anti-apoptotic function is not restricted to 
sensory neurons
In DRGs we observed an approximately 30% partial loss
of all neurons. In previous work, such a loss has also been
reported but not investigated in the hypothalamus of Nec-
din mutants (oxytocin- and LHRH-expressing neurons)
[21]. More generally, we observed an increase of cell death
in a whole Necdin embryo at an early stage of develop-
ment (E10.5), as revealed by an anti-Caspase-3 labelling
(Fig. 7B–C). This increase of apoptosis is not restricted to
the nervous system but is extended to other tissues like
somites or the extremities of members. An expression of
Necdin has previously been reported in these structures
[16].
Thus we propose that Necdin anti-apoptotic/survival
function might be widespread in the nervous system and
other tissues.BMC Developmental Biology 2006, 6:56 http://www.biomedcentral.com/1471-213X/6/56
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Does the loss of sensory neurons explain the sensory 
defects observed in Necdin KO adult mice?
Sensory-motor studies on adult Necdin deficient mice
showed sensory alterations (proprioceptive or nocicep-
tive). These observations lead us to investigate the devel-
oping sensory neurons in DRGs. In accordance, we found
cellular defects and revealed a loss of nociceptive (TrkA)
and proprioceptive (TrkC) sensory neurons. However
considering the cellular defects, we cannot immediately
explain the sensory defects observed: from a loss of sen-
sory TrkA cells, we would expect an increased pain thresh-
old in Necdin deficient mice but we observe the opposite
effect, (a higher sensitivity in the hot-plate test).
Furthermore from a loss of TrkC-cells, we would expect an
alteration of the stretch reflex circuit with a diminution of
the H-wave amplitude whereas, again, we observe the
opposite effect with an increase of the H-wave amplitude
only. A similar effect was observed in Amyotrophic Lateral
Sclerosis disease in which a loss of motoneurons facili-
tates the stretch reflex circuit (increase of H-wave ampli-
tude) [36]. In both cases, these data suggest either a hyper-
excitability of sensory neurons or a lack of neuronal inhi-
bition.
Thus to better understand the physiopathology of Necdin
mutant mice, it will be necessary to take into account 1)
all the cellular effect of Necdin in different neuronal pop-
ulations and/or 2) the physiological compensation used
by the organism to compensate for cellular impairment.
Interestingly, recent data [37] suggest that Necdin pro-
motes GABAergic differentiation; thus, a lack of GABAer-
gic neurons in Ndn KO might lead a lack of neuronal
inhibition.
Conclusion
Our study reveals the sensory-motor behaviour of Necdin
deficient mice. Overall, our data clarify the in vivo function
of Necdin in growth arrest, survival and differentiation
through neurogenesis. We show clearly that, in early
development of the nervous system, Necdin is an anti-
apoptotic or survival factor.
Methods
Breeding and genotyping of Necdin deficient Mice
Necdin deficient mice were generated as previously
described [21]. We used a mouse colony generated on
C57BL6 background (after10 backcross). Because Necdin
is an imprinted gene, paternally expressed only, we
crossed heterozygote males (+ m/- p) with wild type
C57BL/6J females to produce experimental embryos;
thus, in the generated litters, half the embryos were con-
trol and half were Necdin deficient. Age of embryos was
determined by the presence of vaginal plug in the preg-
nant mothers and indicated as embryonic day 0.5. All
embryos were genotyped by PCR with the primer set Nec4
(5'-TGC TAA GTG CCT ACA CTG AG-3') and Nec8 (5'-
GCA TCT TAT TCA TGA GAG AC-3'); generating a 2.6 kb
for the wild type allele and 1,2 kb fragment corresponding
to the mutant allele.
Immunohistochemistry
Embryos were collected, fixed and sectioned (cryostat, 10
or 12 μm). Antibodies used were: NC243 anti-mouse Nec-
din (rabbit polyclonal, 1/500, [38]), anti-Neurofilament
(mouse monoclonal, 1:200, Chemicon); anti-TuJ1
(mouse monoclonal to neuron specific class III β-tubulin,
1:200, Berkeley Antibody); anti-Caspase-3-activated (rab-
bit polyclonal, 1/500, Upstate Biotechnology), anti-
Runx3 (rabbit polyclonal, 1:200, a generous gift of Dr
Yoran Gruner) anti-Parvalbumin (rabbit polyclonal anti-
body, 1/200, Swant Swisszerland) and anti-CGRP
(Chemicon). Primary antibodies were used in a blocking
solution containing 5% Goat serum, 1% BSA, 0.3% Tri-
ton-X-100. Biotinylated secondary antibodies and the
ABC complex from the Vectastain kit (Vector Laboratories,
Burlingame, CA) were used for detection. Alternatively,
fluorophore-conjugated secondary antibodies were used
(1/200; Jackson). Sections were examined on a Zeiss Axi-
oplan 2 microscope with a CARV module. For whole-
mount immunohistochemistry, individual embryos were
processed in a whole-mount staining procedure using the
monoclonal antibody TuJ1 or anti-Caspase-3-activated, as
described [39].
In situ hybridization
In situ hybridization (ISH) was carried out on 10 or 12-μ
m cryosections and was performed as described previ-
ously [16]. The following in situ probes were used: Trka,
Trkb and Trkc (a gift from Patapoutian), Islet [40], Ndn
[16],  p75NTR  (a gift from Dechant). Double in situ
hybridization/immunohistochemistry was carried out as
previously described [41]. Whole-mount ISH was carried
out as previously described.
BrdU labelling
In summary, pregnant mice were administered an intra-
peritoneal injection of 5-bromo-2'-deoxyuridine (BrdU,
50 mg/kg, Sigma) and sacrificed two hours later to allow
BrdU incorporation into proliferating cells. Cryostat sec-
tions were post-fixed for 10 min in PFA 4%, washed in
PBS, and denatured in HCL (2N) and triton-X-100 for 1 h
at 37°C. The section was then neutralized for 10 min in
sodium borate buffer (0,1 M, PH8.5) at room tempera-
ture. Immunohistochemistry was performed using anti
BrdU monoclonal antibody diluted 1/2000 in PBS con-
taining BSA 1%, NGS 5% and triton-X-100. Slides were
incubated in primary antibody overnight at 4°C and
detection was performed using anti-mouse FITC-conju-
gated secondary antibody (Jackson, 1:100).BMC Developmental Biology 2006, 6:56 http://www.biomedcentral.com/1471-213X/6/56
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TUNEL assay
To identify cells undergoing apoptosis, terminal deoxynu-
cleotidyl transferase-mediated biotinylated dUTP nick
end labelling (TUNEL) technique was used. We per-
formed TUNEL using the ApopTag Direct Kit (Oncor) and
followed recommendations. To identify the proportion of
neurons undergoing cell death in the early dorsal root
ganglia of wild type and Necdin embryos, 10 or 12 μm
frozen sections were doubly labeled for Neurofilament
(NF), a neuron-specific marker, and TUNEL. Sections
were first immunolabeled with mouse anti-NF mono-
clonal antibody (see above). This was followed by the
TUNEL technique. The sections were examined and pho-
tographed using an Axioskop microscope. Cells undergo-
ing apoptosis were recognized by an intensely fluorescent
nucleus.
Fluorojade staining
To detect any type of neuronal cell death, Fluorojade (FJ)
labeling was performed on 10 μm thick frozen section as
described previously [42].
Measure of the length of nerves
Whole mount embryos were labeled with Tuj1 antibody
as described above. Axonal outgrowth was measured at
E12.5 (WT, n = 4; Ndn KO, n = 5) and E13.5 (WT, n = 7;
Ndn KO, n = 9). Six peripheral axon bundles, correspond-
ing to the lateral cutaneous branch were analyzed for each
embryo and noted in micrometer.
Explants culture
DRG explants were removed from E13.5 embryos and
grown on coverslips coated with polylysin/laminin in
Neurobasal medium containing 20% FBS and NGF (100
ng/ml). Ganglia were cultured for 20–24 hr then immu-
nostained for Neurofilament prior to axon measurement.
For each ganglion, the axonal surface was measured by
subtracting nucleus area from the whole DRG area
(nucleus + axon). For each animal, 10–12 ganglia were
analyzed. A ratio was then constructed between the wild
type and the mutant DRG.
DRGs volume and cell count
Area of each DRG slide was calculated by using 12 μm
serial section of L1 DRG at P0 from each genotype using
the free UTHSCSA ImageTool program (developed at the
University of Texas Health Science Center at San Antonio,
Texas and available from the Internet by anonymous FTP
from ftp://maxrad6.uthscsa.edu). The DRG volume was
then extrapolated and the values were noted in
micrometer3.
Quantitative analysis to count the number of dying cells
(TUNEL) or Trks and p75NTR positive cells was per-
formed in at least 10 lumbar DRG sections per animal,
and a mean number of positive cells per square millimeter
was determined. All observations reported are based on
analysis of multiple tissue sections from three to five Nec-
din mutant (paternal allele KO) and wild type mice from
the same littermates.
Statistical analysis
Statistical analyses were performed using appropriate
nonparametric statistical tools (unpaired Mann-Whitney
test). In the results, values are indicated as following: (Q2
(Q1, Q3), n). Q2 is the median and, between brackets, Q1
is first quartile and Q3 the second quartile. The level of
significance was set at p < 0.05.
Testing procedures
Gross neurological examination
The general health and basic sensory motor functions
were evaluated using a modified SHIRPA protocol
(EMPRESS, http://eumorphia.org). This analysis is
adapted from that developed by Irwin [43] and from the
SHIRPA protocol [44]. It provides an overview of physical
appearance, body weight, body temperature, neurological
reflexes and sensory abilities. Sensory functions were eval-
uated by measuring or scoring visual ability, audition,
olfaction, tactile perception and vestibular function. Vis-
ual ability was assessed as orientation responses to an
object (a white cotton swab) being moved in each periph-
eral visual field at a distance of 5 cm. Auditory function
was evaluated by scoring Preyer and startle reflexes (pinna
flicking backwards, startle) to 90 dB click noise of 20 kHz
frequency. Olfaction was evaluated by scoring olfactory
exploration of an object (a cotton swab) presented in
front of the animal's muzzle. Tactile perception was eval-
uated by scoring the mouse reaction to pinna and corneal
touch using a cotton wire. Vestibular function was evalu-
ated by measuring righting and contact righting reflexes.
Rotarod test
This test measures the ability of an animal to maintain
balance on a rotating rod (Bioseb, Chaville, France). This
task requires a variety of proprioceptive, vestibular and
fine-tuned motor abilities. Mice were first given three
habituation trials for 60 sec each (one trial at 0 rpm and 2
trials at 4 rpm). Animals were then submitted to 4 testing
trials separated by 5–10 min interval and during which
the rotation speed accelerated from 4 to 40 rpm in 5 min.
Beam walking
The beam walking test is used to evaluate fine motor coor-
dination and proprioceptive function, requiring accurate
paw placement [45]. The apparatus used is a 2 cm diame-
ter and 110 cm long wooden beam, elevated 50 cm above
the ground. The beam is subdivided into 11 segments
allowing rapid estimation of the distance crossed by the
mouse. The first segment at one extremity of the beam isBMC Developmental Biology 2006, 6:56 http://www.biomedcentral.com/1471-213X/6/56
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used as a starting point during testing trials. A goal box
(12 × 12 × 14 cm) is fixed at the other extremity of the
beam.
Animals are first habituated to the goal box for 1 min.
They are then submitted to 3 training trials during which
they are placed at different points of the beam the head
directed to the goal box and allowed to walk the corre-
sponding distance to enter the goal box. After training,
animals are submitted to 3 testing trials during which they
are placed at the extremity of the beam opposite to the
goal box and allowed to walk the beam distance and enter
the goal box. The latency to enter the goal box and the
number of slips (when one or both hindpaws slips later-
ally from the beam) are measured.
String test (traction reflex test)
The apparatus is a wire stretched horizontally 40 cm
above a table. Testing consists of 3 consecutive trials sep-
arated by 5–10 min interval. On each trial the forepaws of
the animal are placed on the thread. The latency the ani-
mal took to catch the wire with its hindpaws was recorded
[46].
Grip test
This test measures the maximal muscle strength using an
isometric dynamometer connected to a grid (Bioseb).
Once the animal is holding the grid with its all paws it is
slowly moved backwards until it releases it. The
dynamometer records the maximal strength developed.
Tail flick test
This apparatus consists of a shutter-controlled lamp as a
heat source (Bioseb). Three consecutive trials with an
interval of about 1–2 min are performed at different sites
of the tail. For each trial, the tail of the animal is placed
under the heat source. The time taken by the animal to
flick its tail is recorded (cut off 20 s).
Hotplate test
The mice are placed into a glass cylinder on a hot plate
adjusted to 52°C (Bioseb) and the latency of the first reac-
tion (licking, moving the paws,) or jump is recorded. Two
consecutive trials with an interval of about 15 min are per-
formed. The first trial ends either immediately after the
mouse displays the first reaction or after 30 s if it does not
show any sign of pain. The second trial ends either imme-
diately after the mouse displays a jump or after 3 min if it
does not show any jump.
Electromyography
EMG recordings were performed under Ketamine-xyla-
zine anaesthesia using a Key Point electromyograph appa-
ratus (Medtronic, France). The body temperature is
maintained at 37°C with a homeothermic blanket (Har-
vard, Paris, France).
- For measuring SNCV, recording electrodes are inserted at
the base of the tail and stimulating electrodes placed 20
mm from the recording needles towards the extremity of
the tail. A ground needle electrode is inserted between the
stimulating and recording needles. Caudal nerve is stimu-
lated with a series of 20 pulses during 0.2 ms each at a
supra-maximal intensity. The mean response of these 20
stimulations is included for statistical analysis.
- CMAP was measured in gastrocnemius or plantar muscle
after stimulation of the sciatic nerve. For this purpose,
stimulating electrodes are placed at the level of the sciatic
nerve and recording electrodes are placed in the gastrocne-
mius or plantar muscle. A ground needle is inserted in
either the contralateral paw. Sciatic nerve is stimulated
with a single 0.2 ms pulse at a supra-maximal intensity.
The amplitude (mV) and the distal latency (ms) of the
responses are measured.
The open field test
The openfield test allows evaluation of anxiety and
exploratory drive. Mice are tested in automated open
fields (Panlab, Barcelona, Spain). The open field arena is
divided into central and peripheral regions. The open
fields are placed in a room homogeneously illuminated at
150 Lux. Each mouse is placed in the periphery of the
open field and allowed to explore freely the apparatus for
30 min, with the experimenter out of the animal's sight.
The distance travelled, the number of rearing, and time
spent in the central and peripheral regions are recorded
over the test session. The latency and number of crosses
into as well as the percent time spent in center area are
used as indices of emotionality/anxiety
Statistical analysis
statistical analyses were performed using appropriate
nonparametric statistical tools: mainly unpaired Mann-
Whitney test. Qualitative parameters (e.g. clinical obser-
vations) were analyzed using χ2 test. The level of signifi-
cance was set at p < 0.05.
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